This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Kips Bay Medical Reports First Quarter 2011 Results & FDA Update

Kips Bay Medical, Inc. (NASDAQ:KIPS) today announced financial results for the three months ended April 2, 2011.

Financial Results

In the first quarter of 2011, net sales and gross profit were $110,000 and $73,000, respectively. Net loss in the first quarter of 2011 was $909,000, or $0.06 per diluted share, compared to our net loss of $3.5 million, or $0.27 per diluted share, in the first quarter of 2010. During the first quarter of 2011, we initiated sales with two new independent distributors, and we achieved a gross margin of 66.4% compared to 69.0% in the fourth quarter of 2010. The gross margin variance resulted from a change in the distributor sales mix during the quarter and the impact of reduced manufacturing volumes on our cost of sales. Also note that our net loss for the first quarter of 2010 included a $2.3 million non-cash charge for an increase in the estimated fair value of an investor stock purchase option liability. This option was exercised in February 2010 at which time the related liability was reclassified to equity.

Balance Sheet and Cash Flow

Cash and short-term investments increased to $17.2 million at April 2, 2011 from $3.8 million as of December 31, 2010. Total current assets increased to $18.2 million from $5.7 million over the same period. These increases were driven by our Initial Public Offering ("IPO") completed in February 2011, from which we realized net proceeds of approximately $13.6 million.

Our current liabilities decreased from $5.7 million as of December 31, 2010 to $5.3 million as of April 2, 2011. This decrease resulted from our payment of certain expenses related to our IPO that were both in accounts payable and accrued liabilities as of December 31, 2010, and paid upon the completion of our IPO.

Cash used in operations declined from $972,000 for the three months ended April 3, 2010 to $215,000 for the three months ended April 2, 2011. This decrease is attributable to the decrease in the deferred offering costs, recorded as part of prepaid expenses and other current assets, which were reclassified to additional paid-in capital upon the completion or our IPO, partially offset by the payment of certain IPO expenses that were recorded in accounts payable and accrued liabilities as of December 31, 2010.

1 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,863.31 -122.30 -0.72%
S&P 500 1,958.26 -14.57 -0.74%
NASDAQ 4,370.6570 -48.3770 -1.09%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs